Concepedia

Zoltán Őrfi

ZŐ

3

Publications

78

Citations

3

H-Index

2014

Active since

Affiliations

Max Planck Institute of Biochemistry(Current)

Semmelweis University

Vichem Chemie (Hungary)

Zoltán Őrfi is an author at Max Planck Institute of Biochemistry specializing in drug discovery, medicine, and medicinal chemistry.

ORCID

Top concepts

Publications per year

2014–2019

3

Publications

3

The chemical class of quinazoline compounds provides a core structure for the design of anticytomegaloviral kinase inhibitors

Corina Hutterer, Stuart T. Hamilton, Mirjam Steingruber et al. · Antiviral Research · 2016 · 48 citations

, , +12

Discovery and development of extreme selective inhibitors of the ITD and D835Y mutant FLT3 kinases

Ferenc Baska, Anna Sipos, Zoltán Őrfi et al. · European Journal of Medicinal Chemistry · 2019 · 16 citations · Full text

, , +9

Discovery and Biological Evaluation of Novel Dual EGFR/c-Met Inhibitors

Bálint Szokol, Pál Gyulavári, Ibolya Kurkó et al. · ACS Medicinal Chemistry Letters · 2014 · 14 citations · Full text

, , +13

Rows per page

1–3 of 3